This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to
About the Federal Register
on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Rule
Enter a search term or FR citation e.g.
88 FR 38230 FR 78782024-13208USDA09/05/24RULE0503-AA39SORN
Choosing an item from
full text search results
will bring you to those results. Pressing enter in the search box
will also bring you to search results.
Choosing an item from
suggestions
will bring you directly to the content.
This rule will be effective on June 21, 2010, unless we receive written adverse comments or written notice of intent to submit adverse comments on or before May 21, 2010. If we receive written adverse comments or written notice of intent to submit adverse comments, we will publish a document in the Federal Register withdrawing this rule before the effective date.
Table of Contents
Enhanced Content - Table of Contents
This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.
Document page views are updated periodically throughout the day and are
cumulative counts for this document. Counts are subject to sampling,
reprocessing and revision (up or down) throughout the day.
Page views
82
as of
07/20/2026 at 6:15 am EDT
Other Formats
Enhanced Content - Other Formats
This document is also available in the following formats:
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
AGENCY:
Animal and Plant Health Inspection Service, USDA.
ACTION:
Direct final rule.
SUMMARY:
We are amending the Virus-Serum-Toxin Act regulations concerning veterinary biological products to update the addresses provided for units within the Center for Veterinary Biologics. We are also making several nonsubstantive technical changes to the regulations to update information concerning the number of copies of Outlines of Production and labeling to submit, and to provide information concerning using the Internet to obtain forms and apply for veterinary biologics permits.
DATES:
This rule will be effective on June 21, 2010, unless we receive written adverse comments or written notice of intent to submit adverse comments on or before May 21, 2010. If we receive written adverse comments or written notice of intent to submit adverse comments, we will publish a document in the
Federal Register
withdrawing this rule before the effective date.
ADDRESSES:
You may submit comments by either of the following methods:
Postal Mail/Commercial Delivery: Please send one copy of your comment to Docket No. APHIS-2009-0069, Regulatory Analysis and Development, PPD, APHIS, Station 3A-03.8, 4700 River Road Unit 118, Riverdale, MD 20737-1238. Please state that your comment refers to Docket No. APHIS-2009-0069.
Reading Room:
You may read any comments that we receive on this docket in our reading room. The reading room is located in room 1141 of the USDA South Building, 14th Street and Independence Avenue SW., Washington, DC. Normal reading room hours are 8 a.m. to 4:30 p.m., Monday through Friday, except holidays. To be sure someone is there to help you, please call (202) 690-2817 before coming.
Other Information:
Additional information about APHIS and its programs is available on the Internet at (
http://www.aphis.usda.gov).
FOR FURTHER INFORMATION CONTACT:
Dr. Albert P. Morgan, Chief of Operational Support Section, Center for Veterinary Biologics, Policy, Evaluation, and Licensing, VS, APHIS, 4700 River Road Unit 148, Riverdale, MD 20737-1231; (301) 734-8245.
SUPPLEMENTARY INFORMATION:
Background
The regulations in Title 9, Code of Federal Regulations (9 CFR), parts 101 through 118 (referred to below as the regulations), contain provisions implementing the Virus-Serum-Toxin Act, as amended (21 U.S.C. 151-159). The regulations in 9 CFR part 124 contain procedural requirements for patent extensions for veterinary biologics under 35 U.S.C. 156. In accordance with the procedures explained below under “Dates,” this final rule makes several nonsubstantive technical changes to those regulations to update their provisions. Specifically:
We will amend the addresses throughout the regulations to reflect the relocation of the Center for Veterinary Biologics to new facilities in Ames, IA.
We will amend9 CFR part 102, § 102.3(b)(2)(i), 9 CFR part 104, § 104.5(a)(4), and 9 CFR part 114, §§ 114.8(c) and 114.9(a)(1), (a)(5), and (a)(7) regarding the number of copies of the Outline of Production or revised pages of an Outline of Production, or special outline that are required to be submitted in support of an application for veterinary biological product license or permit.
We will amend9 CFR part 103, § 103.3(d), and 9 CFR part 112, § 112.5(d)(1)(iii) and (d)(1)(iv) regarding the number of copies of finished labels that are required to be submitted for review and filing.
We will amend9 CFR part 103, § 104.3(a), and 9 CFR part 112, § 112.5(a), to indicate that the Internet may be used to obtain forms and apply for certain veterinary biologics permits.
We will amend9 CFR part 104, § 104.5(a)(1), and 9 CFR part 108, § 108.7, regarding the number of copies of all plot plans, blueprints, and legends required to be submitted for review and filing.
Dates
We are publishing this rule without a prior proposal because we view this action as noncontroversial and anticipate no adverse public comment. This rule will be effective, as published in this document, on June 21, 2010, unless we receive written adverse comments or written notice of intent to submit adverse comments on or before May 21, 2010.
Adverse comments are comments that suggest the rule should not be adopted or that suggest the rule should be changed.
If we receive written adverse comments or written notice of intent to submit adverse comments, we will publish a document in the
Federal Register
withdrawing this rule before the effective date. We will then publish a proposed rule for public comment.
As discussed above, if we receive no written adverse comments or written notice of intent to submit adverse comments within 30 days of publication of this direct final rule, this direct final rule will become effective 60 days following its publication. We will publish a document in the
Federal Register
, before the effective date of this direct final rule, confirming that it is effective on the date indicated in this document.
This rule is subject to Executive Order 12866. However, for this action, the Office of Management and Budget has waived its review under Executive Order 12866.
( printed page 20772)
This direct final rule will affect all licensed manufacturers of veterinary biologics. Currently, there are approximately 125 veterinary biologics manufacturers, including permittees. According to the standards of the Small Business Administration, most veterinary biologics establishments are small entities.
The provisions of this direct final rule that update addresses and indicate the availability of forms on the Internet will have no economic effect on any entities, large or small. The provisions that reduce from three to two the number of copies of certain forms, labels, plot plans, blueprints, and legends that regulated entities are required to submit in specific cases may result in some cost savings to those entities, but those savings will be inconsequential.
Under these circumstances, the Administrator of the Animal and Plant Health Inspection Service has determined that this action will not have a significant economic impact on a substantial number of small entities.
This program/activity is listed in the Catalog of Federal Domestic Assistance under No. 10.025 and is subject to Executive Order 12372, which requires intergovernmental consultation with State and local officials. (See 7 CFR part 3015, subpart V.)
This direct final rule has been reviewed under Executive Order 12988, Civil Justice Reform. It is not intended to have retroactive effect. This rule would not preempt any State or local laws, regulations, or policies where they are necessary to address local disease conditions or eradication programs. However, where safety, efficacy, purity, and potency of biological products are concerned, it is the Agency’s intent to occupy the field. This includes, but is not limited to, the regulation of labeling. Under the Act, Congress clearly intended that there be national uniformity in the regulation of these products. There are no administrative proceedings which must be exhausted prior to a judicial challenge to the regulations under this rule.
Paperwork Reduction Act
This rule contains no new information collection or recordkeeping requirements under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501et seq.). Further, this rule will reduce information collection or recordkeeping requirements in 9 CFR parts 102, 103, 104, 108, 112, and 114.
3. In § 102.5, paragraph (e), the second sentence is amended by removing the words “Licensing and Policy Development, 510 South 17th Street, Suite 104, Ames, IA 50010-8197” and adding the words “Policy, Evaluation, and Licensing, 1920 Dayton Avenue, P.O. Box 844, Ames, IA 50010” in their place.
PART 103—EXPERIMENTAL PRODUCTION, DISTRIBUTION, AND EVALUATION OF BIOLOGICAL PRODUCTS PRIOR TO LICENSING
4. The authority citation for part 103 continues to read as follows:
a. In paragraph (a), in the first sentence, by removing the words “furnished by Animal and Plant Health inspection Service upon request” and adding the words “available on the
( printed page 20773)
Internet at (
http://www.aphis.usda.gov/animal_health/vet_biologics/vb_forms.shtml) ” in their place.
b. In paragraph (d)(1)(iii), in the first sentence, by removing the words “three copies” and adding the words “two copies” in their place and, in the second sentence, by removing the words “Two copies” and adding the words “One copy” in their place.
c. In paragraph (d)(1)(iv), in the first sentence, by removing the words “three copies” and adding the words “two copies” in their place and, in the fifth sentence, by removing the words “Two copies” and adding the words “One copy” in their place.
PART 113—STANDARD REQUIREMENTS
13. The authority citation for part 113 continues to read as follows:
a. In paragraph (a)(2), in the third sentence, by removing the words “510 South 17th Street, Suite 104, Ames, IA 50010-8197” and adding the words “1920 Dayton Avenue, P.O. Box 844, Ames, IA 50010” in their place.
b. In paragraph (a)(3), in the second sentence, by removing the words “510 South 17th Street, Suite 104, Ames, IA 50010-8197” and adding the words “1920 Dayton Avenue, P.O. Box 844, Ames, IA 50010” in their place.
c. In paragraph (c)(1)(iv), in the first sentence, by removing the words “510 South 17th Street, Suite 104, Ames, IA 50010-8197” and adding the words “1920 Dayton Avenue, P.O. Box 844, Ames, IA 50010” in their place.
d. In paragraph (c)(2)(iv)(A), in the second sentence, by removing the words “Licensing and Policy Development, 510 South 17th Street, Suite, 104, Ames, IA 50010-8197” and adding the words “Policy, Evaluation, and Licensing, 1920 Dayton Avenue, P.O. Box 844, Ames, IA 50010” in their place.
15. In § 113.209, paragraph (b)(1), the fifth sentence is amended by removing the words “1800 Dayton Avenue, P.O. Box 844, Ames, IA 50010; phone (515) 239-8331; fax (515) 239-8673” and adding the words “1920 Dayton Avenue, P.O. Box 844, Ames, IA 50010; phone (515) 337-6100; fax (515) 337-6120” in their place and, in the seventh sentence, by removing the words “Licensing, and Policy Development, 4700 River Road, Riverdale, MD” and adding the words “Policy, Evaluation, and Licensing, 1920 Dayton Avenue, P.O. Box 844, Ames, IA 50010” in their place.
PART 114—PRODUCTION REQUIREMENTS FOR BIOLOGICAL PRODUCTS
16. The authority citation for part 114 continues to read as follows:
(c) One copy of the Outline of Production shall be retained by the Animal and Plant Health Inspection Service and one copy returned to the licensee or permittee.
20. In § 116.5, paragraph (b), the second sentence is amended by removing the words “510 South 17th Street, Suite 104, Ames, IA 50010-8197; by electronic mail to ( cvb@aphis.usda.gov); by fax to (515) 232-7120; or by telephone to (515) 232-5785” and adding the words “1920 Dayton Avenue, P.O. Box 844, Ames, IA 50010; by electronic mail to (
cvb@aphis.usda.gov); by fax to (515) 337-6120; or by telephone to (515) 337-6100” in their place.
PART 124—PATENT TERM RESTORATION
21. The authority citation for part 124 continues to read as follows:
22. In § 124.22, paragraph (a), the second sentence is amended by removing the words “Licensing, and Policy Development, 510 South 17th Street, Suite 104, Ames, IA 50010-8197” and adding the words “Policy, Evaluation, and Licensing, 1920 Dayton Avenue, P.O. Box 844, Ames, IA 50010” in their place.
23. In § 124.40, paragraph (b)(3) is amended by removing the words “Licensing and Policy Development, 510 South 17th Street, Suite 104, Ames, IA 50010-8197” and adding the words “Policy, Evaluation, and Licensing, 1920 Dayton Avenue, P.O. Box 844, Ames, IA 50010” in their place.
Done in Washington, DC, this 14th
day of April 2010.
Kevin Shea,
Acting Administrator, Animal and Plant Health Inspection Service.